Allowed Publications
Slot System
Featured Buckets
Featured Buckets Admin

ACE Inhibitors and ARBs for Diabetes Prevention

Article Type
Changed
Display Headline
ACE Inhibitors and ARBs for Diabetes Prevention

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(12)
Publications
Topics
Page Number
63
Legacy Keywords
angiotension, converting, enzyme, ACE, receptor, blocker, ARB, hypertension, coronary, artery, disease, heart, failure, diabetes, preventive medicineangiotension, converting, enzyme, ACE, receptor, blocker, ARB, hypertension, coronary, artery, disease, heart, failure, diabetes, preventive medicine
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(12)
Issue
Federal Practitioner - 22(12)
Page Number
63
Page Number
63
Publications
Publications
Topics
Article Type
Display Headline
ACE Inhibitors and ARBs for Diabetes Prevention
Display Headline
ACE Inhibitors and ARBs for Diabetes Prevention
Legacy Keywords
angiotension, converting, enzyme, ACE, receptor, blocker, ARB, hypertension, coronary, artery, disease, heart, failure, diabetes, preventive medicineangiotension, converting, enzyme, ACE, receptor, blocker, ARB, hypertension, coronary, artery, disease, heart, failure, diabetes, preventive medicine
Legacy Keywords
angiotension, converting, enzyme, ACE, receptor, blocker, ARB, hypertension, coronary, artery, disease, heart, failure, diabetes, preventive medicineangiotension, converting, enzyme, ACE, receptor, blocker, ARB, hypertension, coronary, artery, disease, heart, failure, diabetes, preventive medicine
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Levothyroxine for Hypothyroidism: How High Can You Start?

Article Type
Changed
Display Headline
Levothyroxine for Hypothyroidism: How High Can You Start?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(12)
Publications
Page Number
63
Legacy Keywords
levothyroxine, hypothyroidism, ischemic, heart, disease, cardiovascular, serum, starting, dose, initiallevothyroxine, hypothyroidism, ischemic, heart, disease, cardiovascular, serum, starting, dose, initial
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(12)
Issue
Federal Practitioner - 22(12)
Page Number
63
Page Number
63
Publications
Publications
Article Type
Display Headline
Levothyroxine for Hypothyroidism: How High Can You Start?
Display Headline
Levothyroxine for Hypothyroidism: How High Can You Start?
Legacy Keywords
levothyroxine, hypothyroidism, ischemic, heart, disease, cardiovascular, serum, starting, dose, initiallevothyroxine, hypothyroidism, ischemic, heart, disease, cardiovascular, serum, starting, dose, initial
Legacy Keywords
levothyroxine, hypothyroidism, ischemic, heart, disease, cardiovascular, serum, starting, dose, initiallevothyroxine, hypothyroidism, ischemic, heart, disease, cardiovascular, serum, starting, dose, initial
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Oral Contraceptives and the Diabetic Kidney

Article Type
Changed
Display Headline
Oral Contraceptives and the Diabetic Kidney

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(11)
Publications
Topics
Page Number
30
Legacy Keywords
oral, contraceptives, diabetes, diabetic, kidney, OC, macroalbuminuria, women, woman, renal, plasma, flow, RPF, angiotensin, RAS, renin-angitensin, system, activation, pregnancy, nephropathyoral, contraceptives, diabetes, diabetic, kidney, OC, macroalbuminuria, women, woman, renal, plasma, flow, RPF, angiotensin, RAS, renin-angitensin, system, activation, pregnancy, nephropathy
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(11)
Issue
Federal Practitioner - 22(11)
Page Number
30
Page Number
30
Publications
Publications
Topics
Article Type
Display Headline
Oral Contraceptives and the Diabetic Kidney
Display Headline
Oral Contraceptives and the Diabetic Kidney
Legacy Keywords
oral, contraceptives, diabetes, diabetic, kidney, OC, macroalbuminuria, women, woman, renal, plasma, flow, RPF, angiotensin, RAS, renin-angitensin, system, activation, pregnancy, nephropathyoral, contraceptives, diabetes, diabetic, kidney, OC, macroalbuminuria, women, woman, renal, plasma, flow, RPF, angiotensin, RAS, renin-angitensin, system, activation, pregnancy, nephropathy
Legacy Keywords
oral, contraceptives, diabetes, diabetic, kidney, OC, macroalbuminuria, women, woman, renal, plasma, flow, RPF, angiotensin, RAS, renin-angitensin, system, activation, pregnancy, nephropathyoral, contraceptives, diabetes, diabetic, kidney, OC, macroalbuminuria, women, woman, renal, plasma, flow, RPF, angiotensin, RAS, renin-angitensin, system, activation, pregnancy, nephropathy
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Stop the Posttransplant Corticosteroids Sooner?

Article Type
Changed
Display Headline
Stop the Posttransplant Corticosteroids Sooner?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(11)
Publications
Topics
Page Number
30
Legacy Keywords
posttransplant, transplant, immunosuppressive, drug, treatment, renal, cardiovascular, weight, gain, corticosteroid, obesity, kidney disease, surgery, withdrawal, early, long-termposttransplant, transplant, immunosuppressive, drug, treatment, renal, cardiovascular, weight, gain, corticosteroid, obesity, kidney disease, surgery, withdrawal, early, long-term
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(11)
Issue
Federal Practitioner - 22(11)
Page Number
30
Page Number
30
Publications
Publications
Topics
Article Type
Display Headline
Stop the Posttransplant Corticosteroids Sooner?
Display Headline
Stop the Posttransplant Corticosteroids Sooner?
Legacy Keywords
posttransplant, transplant, immunosuppressive, drug, treatment, renal, cardiovascular, weight, gain, corticosteroid, obesity, kidney disease, surgery, withdrawal, early, long-termposttransplant, transplant, immunosuppressive, drug, treatment, renal, cardiovascular, weight, gain, corticosteroid, obesity, kidney disease, surgery, withdrawal, early, long-term
Legacy Keywords
posttransplant, transplant, immunosuppressive, drug, treatment, renal, cardiovascular, weight, gain, corticosteroid, obesity, kidney disease, surgery, withdrawal, early, long-termposttransplant, transplant, immunosuppressive, drug, treatment, renal, cardiovascular, weight, gain, corticosteroid, obesity, kidney disease, surgery, withdrawal, early, long-term
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

rt-PA for Stroke: Why the Reluctance?

Article Type
Changed
Display Headline
rt-PA for Stroke: Why the Reluctance?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(10)
Publications
Topics
Page Number
54
Legacy Keywords
recombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trialrecombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trial
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(10)
Issue
Federal Practitioner - 22(10)
Page Number
54
Page Number
54
Publications
Publications
Topics
Article Type
Display Headline
rt-PA for Stroke: Why the Reluctance?
Display Headline
rt-PA for Stroke: Why the Reluctance?
Legacy Keywords
recombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trialrecombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trial
Legacy Keywords
recombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trialrecombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trial
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Hypersensitivity to Once Daily Abacavir

Article Type
Changed
Display Headline
Hypersensitivity to Once Daily Abacavir

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(10)
Publications
Topics
Page Number
54
Legacy Keywords
HIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severeHIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severe
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(10)
Issue
Federal Practitioner - 22(10)
Page Number
54
Page Number
54
Publications
Publications
Topics
Article Type
Display Headline
Hypersensitivity to Once Daily Abacavir
Display Headline
Hypersensitivity to Once Daily Abacavir
Legacy Keywords
HIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severeHIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severe
Legacy Keywords
HIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severeHIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severe
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

How Valuable Are Short-Acting Insulin Analogs?

Article Type
Changed
Display Headline
How Valuable Are Short-Acting Insulin Analogs?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(10)
Publications
Topics
Page Number
54
Legacy Keywords
short, acting, insulin, analogs, diabetes, type 1, type 2, glycosolated hemoglobin, HBA1c, gestational, glycemic control, regular, long-termshort, acting, insulin, analogs, diabetes, type 1, type 2, glycosolated hemoglobin, HBA1c, gestational, glycemic control, regular, long-term
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(10)
Issue
Federal Practitioner - 22(10)
Page Number
54
Page Number
54
Publications
Publications
Topics
Article Type
Display Headline
How Valuable Are Short-Acting Insulin Analogs?
Display Headline
How Valuable Are Short-Acting Insulin Analogs?
Legacy Keywords
short, acting, insulin, analogs, diabetes, type 1, type 2, glycosolated hemoglobin, HBA1c, gestational, glycemic control, regular, long-termshort, acting, insulin, analogs, diabetes, type 1, type 2, glycosolated hemoglobin, HBA1c, gestational, glycemic control, regular, long-term
Legacy Keywords
short, acting, insulin, analogs, diabetes, type 1, type 2, glycosolated hemoglobin, HBA1c, gestational, glycemic control, regular, long-termshort, acting, insulin, analogs, diabetes, type 1, type 2, glycosolated hemoglobin, HBA1c, gestational, glycemic control, regular, long-term
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Treating Hospital-Acquired Malnutrition

Article Type
Changed
Display Headline
Treating Hospital-Acquired Malnutrition

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(10)
Publications
Page Number
53
Legacy Keywords
megestrol, acetate, elderly, hospital, acquired, malnutrition, appetite, prealbumin, dischargedmegestrol, acetate, elderly, hospital, acquired, malnutrition, appetite, prealbumin, discharged
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(10)
Issue
Federal Practitioner - 22(10)
Page Number
53
Page Number
53
Publications
Publications
Article Type
Display Headline
Treating Hospital-Acquired Malnutrition
Display Headline
Treating Hospital-Acquired Malnutrition
Legacy Keywords
megestrol, acetate, elderly, hospital, acquired, malnutrition, appetite, prealbumin, dischargedmegestrol, acetate, elderly, hospital, acquired, malnutrition, appetite, prealbumin, discharged
Legacy Keywords
megestrol, acetate, elderly, hospital, acquired, malnutrition, appetite, prealbumin, dischargedmegestrol, acetate, elderly, hospital, acquired, malnutrition, appetite, prealbumin, discharged
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Hydroxyurea vs. Anagrelide in Essential Thrombocythemia

Article Type
Changed
Display Headline
Hydroxyurea vs. Anagrelide in Essential Thrombocythemia

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(10)
Publications
Page Number
53
Legacy Keywords
thrombocythemia, hemorrhage, thrombosis, arterial, stem, cell, disorder, hydroxyurea, aspirin, anagrelidethrombocythemia, hemorrhage, thrombosis, arterial, stem, cell, disorder, hydroxyurea, aspirin, anagrelide
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(10)
Issue
Federal Practitioner - 22(10)
Page Number
53
Page Number
53
Publications
Publications
Article Type
Display Headline
Hydroxyurea vs. Anagrelide in Essential Thrombocythemia
Display Headline
Hydroxyurea vs. Anagrelide in Essential Thrombocythemia
Legacy Keywords
thrombocythemia, hemorrhage, thrombosis, arterial, stem, cell, disorder, hydroxyurea, aspirin, anagrelidethrombocythemia, hemorrhage, thrombosis, arterial, stem, cell, disorder, hydroxyurea, aspirin, anagrelide
Legacy Keywords
thrombocythemia, hemorrhage, thrombosis, arterial, stem, cell, disorder, hydroxyurea, aspirin, anagrelidethrombocythemia, hemorrhage, thrombosis, arterial, stem, cell, disorder, hydroxyurea, aspirin, anagrelide
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Fibrates for MI Risk in Metabolic Syndrome

Article Type
Changed
Display Headline
Fibrates for MI Risk in Metabolic Syndrome

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(9)
Publications
Topics
Page Number
32
Legacy Keywords
cardiovascular disease, fibrates, metabolic syndrome, myocardial infarction, MI, bezafibrate retard, risk, fibric acidcardiovascular disease, fibrates, metabolic syndrome, myocardial infarction, MI, bezafibrate retard, risk, fibric acid
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(9)
Issue
Federal Practitioner - 22(9)
Page Number
32
Page Number
32
Publications
Publications
Topics
Article Type
Display Headline
Fibrates for MI Risk in Metabolic Syndrome
Display Headline
Fibrates for MI Risk in Metabolic Syndrome
Legacy Keywords
cardiovascular disease, fibrates, metabolic syndrome, myocardial infarction, MI, bezafibrate retard, risk, fibric acidcardiovascular disease, fibrates, metabolic syndrome, myocardial infarction, MI, bezafibrate retard, risk, fibric acid
Legacy Keywords
cardiovascular disease, fibrates, metabolic syndrome, myocardial infarction, MI, bezafibrate retard, risk, fibric acidcardiovascular disease, fibrates, metabolic syndrome, myocardial infarction, MI, bezafibrate retard, risk, fibric acid
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media